196 related articles for article (PubMed ID: 25228998)
1. Clinical features of fixed drug eruption at a tertiary hospital in Korea.
Jung JW; Cho SH; Kim KH; Min KU; Kang HR
Allergy Asthma Immunol Res; 2014 Sep; 6(5):415-20. PubMed ID: 25228998
[TBL] [Abstract][Full Text] [Related]
2. Flurbiprofen-induced generalized bullous fixed drug eruption.
Balta I; Simsek H; Simsek GG
Hum Exp Toxicol; 2014 Jan; 33(1):106-8. PubMed ID: 23703815
[TBL] [Abstract][Full Text] [Related]
3. An Observational Study of Fixed Drug Eruption in A Tertiary Care Hospital in Bangladesh.
Jannat T; Uddin J; Zakariah R; Talukder RI; Mortuza MG; Islam B; Islam R; Sumi SA
Mymensingh Med J; 2023 Jan; 32(1):49-53. PubMed ID: 36594300
[TBL] [Abstract][Full Text] [Related]
4. Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption.
Ben Fadhel N; Chaabane A; Ammar H; Ben Romdhane H; Soua Y; Chadli Z; Zili J; Boughattas NA; Ben Fredj N; Aouam K
Contact Dermatitis; 2019 Nov; 81(5):336-340. PubMed ID: 31291002
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide-Induced Fixed Drug Eruption Followed by Etoricoxib-Induced Fixed Drug Eruption: An Unusual Case Report and Review of the Literature.
Makris M; Papapostolou N; Koumprentziotis IA; Pappa G; Katoulis AC
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541809
[TBL] [Abstract][Full Text] [Related]
6. Cefepime-Induced Generalized Fixed Drug Eruption With Morbilliform Rash.
Clark GP; Caldwell HM; Coop CA; Neaves BI; Barnes PW
Cureus; 2024 Jan; 16(1):e53011. PubMed ID: 38410317
[TBL] [Abstract][Full Text] [Related]
7. Fixed Drug Eruption Associated with Nonsteroidal Anti-Inflammatory Drugs for Menstrual Pain: A Case Report.
Shimizu R; Tsushima F; Komiya R; Yamagata Y; Harada H
Case Rep Dermatol; 2022; 14(1):6-11. PubMed ID: 35221960
[TBL] [Abstract][Full Text] [Related]
8. A Clinico-Epidemiological Study of Fixed Drug Eruption with a Special Focus on the Causative Agent and the Clinical Patterns.
Halder D; Das S; De A
Indian Dermatol Online J; 2024; 15(2):255-258. PubMed ID: 38550806
[TBL] [Abstract][Full Text] [Related]
9. Drug related clinical pattern in fixed drug eruption.
Ozkaya-Bayazit E; Bayazit H; Ozarmagan G
Eur J Dermatol; 2000 Jun; 10(4):288-91. PubMed ID: 10846256
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features and Drug Characteristics of Patients with Generalized Fixed Drug Eruption in the West of Iran (2005-2014).
Kavoussi H; Rezaei M; Derakhshandeh K; Moradi A; Ebrahimi A; Rashidian H; Kavoussi R
Dermatol Res Pract; 2015; 2015():236703. PubMed ID: 26783389
[TBL] [Abstract][Full Text] [Related]
11. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption.
Patel S; John AM; Handler MZ; Schwartz RA
Am J Clin Dermatol; 2020 Jun; 21(3):393-399. PubMed ID: 32002848
[TBL] [Abstract][Full Text] [Related]
12. Piroxicam-induced fixed drug eruption: Cross-reactivity with meloxicam.
Ben Romdhane H; Ammar H; Ben Fadhel N; Chadli Z; Ben Fredj N; Boughattas NA; Chaabane A; Aouam K
Contact Dermatitis; 2019 Jul; 81(1):24-26. PubMed ID: 30663057
[TBL] [Abstract][Full Text] [Related]
13. A three-year-analysis of fixed drug eruptions in hospital settings in France.
Brahimi N; Routier E; Raison-Peyron N; Tronquoy AF; Pouget-Jasson C; Amarger S; Machet L; Amsler E; Claeys A; Sassolas B; Leroy D; Grange A; Dupuy A; Cordel N; Bonnetblanc JM; Milpied B; Doutre MS; Guinnepain MT; Barbaud A; Chosidow O; Roujeau JC; Lebrun-Vignes B; Descamps V
Eur J Dermatol; 2010; 20(4):461-4. PubMed ID: 20507840
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs-induced generalized fixed drug eruption: two cases.
Bilgili SG; Calka O; Karadag AS; Akdeniz N; Kosem M
Hum Exp Toxicol; 2012 Feb; 31(2):197-200. PubMed ID: 21677025
[TBL] [Abstract][Full Text] [Related]
15. An update of fixed drug eruptions in Singapore.
Heng YK; Yew YW; Lim DS; Lim YL
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1539-44. PubMed ID: 25491106
[TBL] [Abstract][Full Text] [Related]
16. Naproxen-induced generalized bullous fixed drug eruption.
Bandino JP; Wohltmann WE; Bray DW; Hoover AZ
Dermatol Online J; 2009 Nov; 15(11):4. PubMed ID: 19951640
[TBL] [Abstract][Full Text] [Related]
17. Fixed-drug Eruptions: What can we Learn from a Case Series?
Jhaj R; Chaudhary D; Asati D; Sadasivam B
Indian J Dermatol; 2018; 63(4):332-337. PubMed ID: 30078879
[TBL] [Abstract][Full Text] [Related]
18. Bullous fixed drug eruption: A potential diagnostic pitfall: a study of 18 cases.
Zaouak A; Ben Salem F; Ben Jannet S; Hammami H; Fenniche S
Therapie; 2019 Oct; 74(5):527-530. PubMed ID: 31006486
[TBL] [Abstract][Full Text] [Related]
19. [Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis].
Huynh VA; Lungoci E; Villani A; Ben Said B; Hacard F; Nicolas JF; Bérard F
Ann Dermatol Venereol; 2016 Dec; 143(12):852-855. PubMed ID: 27080820
[TBL] [Abstract][Full Text] [Related]
20. Peculiar unilateral fixed drug eruption of the breast.
Li H; Wiederkehr M; Rao Bk; Samady JA; Gardner B; Lambert WC; Schwartz RA
Int J Dermatol; 2002 Feb; 41(2):96-8. PubMed ID: 11982645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
